Picture Campus Berlin-Buch GmbH BBC BerlinBioCube Now Open Latest News 650x100px
Organisation › Details

Pelago Bioscience AB

Spun out from the Karolinska Institute, Stockholm Sweden, Pelago Bioscience AB was founded in 2013 to provide and develop the patented Cellular Thermal Shift Assay (CETSA™) for use in determination and quantification of drug–target interactions. Pelago Bioscience has during the first two operational years delivered in situ target engagement studies to more than a dozen pharmaceutical companies to accelerate their preclinical and clinical drug discovery projects. Using CETSA data and applications, drug discovery R&D companies are able to make better and more informed decisions at earlier stages in their projects. This reduces time and money spent on the non-optimal compounds and allows faster development of more efficacious new drugs. *


Period Start 2013-01-01 splitoff
  Predecessor Karolinska Institutet
Products Industry contract research (drugs)
  Industry 2 Cellular Thermal Shift Assay (CETSA™ method)
Person Person Dabrowski, Michael (Pelago Bioscience AB 201506 CEO)
  Street 20 Banvaktsvägen
  City 17148 Solna
    Address record changed: 2020-12-02
Basic data Employees A: 1 to 10 (2014-11-08)
    * Document for »About Section«: 
Record changed: 2023-07-10


Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Campus Berlin-Buch GmbH CBB Location of Future Innovation 650x300px

» top